Treatment of Persistent Migraine Headaches
Start with combination therapy of a triptan plus an NSAID or acetaminophen as first-line treatment for persistent moderate to severe migraines, initiating treatment as early as possible after headache onset. 1
Acute Treatment Algorithm
First-Line Therapy
For mild to moderate attacks:
- Begin with NSAIDs alone: aspirin, ibuprofen, naproxen sodium, or diclofenac potassium 1
- Acetaminophen can be used but has lower efficacy and should only be chosen if NSAIDs are contraindicated 2
For moderate to severe attacks:
- Use combination therapy with a triptan (sumatriptan, rizatriptan, naratriptan, or zolmitriptan) plus an NSAID or acetaminophen 1
- This combination approach provides superior efficacy compared to monotherapy 1
- Triptans demonstrate headache response rates of 52-62% at 2 hours and 65-79% at 4 hours, compared to 17-27% with placebo 3
Second-Line Options (When First-Line Fails)
If combination triptan-NSAID therapy is inadequate or not tolerated:
- CGRP antagonists-gepants: rimegepant, ubrogepant, or zavegepant 1
- Ergot alkaloid: dihydroergotamine (particularly intranasal formulation) 1, 2
Third-Line Option
- Lasmiditan (a ditan) should be reserved for patients who fail all other treatments in this guideline 1
Adjunctive Therapy for Nausea/Vomiting
- Add non-oral triptans with antiemetics (such as metoclopramide or domperidone) for patients experiencing severe nausea or vomiting 1, 4
Critical Medications to AVOID
Never use opioids or butalbital-containing medications for persistent migraine treatment due to questionable efficacy, significant adverse effects, dependency risk, and potential for medication overuse headache 1, 2
Medication Overuse Headache Prevention
Be vigilant about frequency of acute medication use:
- NSAIDs: limit to <15 days per month 1
- Triptans: limit to <10 days per month 1
- Medication overuse headache develops when acute medications are used on ≥15 days per month for ≥3 months, presenting as daily or near-daily headaches 1
- If overuse is occurring, abrupt withdrawal is preferred (except for opioids), combined with patient education 1
When to Add Preventive Therapy
Consider initiating preventive medications when:
- Migraines occur frequently (≥2 days per month) 4
- Acute treatment provides inadequate response despite optimization 1
- Patient is at risk for medication overuse headache 1
Evidence-based preventive options for chronic migraine include:
- Topiramate (first choice due to lower cost) 1
- OnabotulinumtoxinA 1
- CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab) - typically reserved for patients who have failed 2-3 other preventive medications 1
Essential Lifestyle Modifications
Counsel all patients on these evidence-based modifications:
- Maintain adequate hydration and regular meal schedule 1, 2
- Ensure sufficient and consistent sleep (7-9 hours nightly) 1
- Engage in regular moderate to intense aerobic exercise 1
- Practice stress management through relaxation techniques or mindfulness 1
- Pursue weight loss if overweight or obese, as obesity is a risk factor for chronic migraine transformation 1
- Identify and modify personal migraine triggers through detailed history-taking 1
Special Populations
For pregnant or breastfeeding women:
- Discuss adverse effects of all pharmacologic treatments during pregnancy and lactation before prescribing 1
- Acetaminophen is the safest option during pregnancy 5
- Sumatriptan may be considered in selected pregnant patients and is compatible with breastfeeding 5
Cost Considerations
- Prescribe less costly recommended medications when equally effective 1
- Generic NSAIDs and triptans are significantly less expensive than newer CGRP antagonists (annualized costs: gepants $4,959-$8,800 vs. generic triptans/NSAIDs <$500) 1
Common Pitfalls to Avoid
- Do not delay treatment - early initiation maximizes efficacy 1, 2
- Do not use triptan monotherapy when combination therapy is appropriate - adding an NSAID or acetaminophen improves outcomes 1
- Do not continue ineffective treatments - if a medication fails after adequate trial, switch within or between classes 6
- Do not overlook comorbidities - depression, anxiety, sleep disturbances, and chronic pain conditions are common and influence treatment selection 1